User profiles for M. Diehn
Maximilian DiehnStanford University Verified email at stanford.edu Cited by 46574 |
Circulating tumor DNA analysis in patients with cancer: American Society of Clinical Oncology and College of American Pathologists joint review
Purpose.— Clinical use of analytical tests to assess genomic variants in circulating tumor
DNA (ctDNA) is increasing. This joint review from the American Society of Clinical Oncology …
DNA (ctDNA) is increasing. This joint review from the American Society of Clinical Oncology …
[HTML][HTML] Liquid biopsy for advanced NSCLC: a consensus statement from the international association for the study of lung cancer
…, ME Arcila, F Barlesi, T Bivona, M Diehn… - Journal of Thoracic …, 2021 - Elsevier
Although precision medicine has had a mixed impact on the clinical management of
patients with advanced-stage cancer overall, for NSCLC, and more specifically for lung …
patients with advanced-stage cancer overall, for NSCLC, and more specifically for lung …
[HTML][HTML] ctDNA applications and integration in colorectal cancer: an NCI Colon and Rectal–Anal Task Forces whitepaper
…, RB Corcoran, DA Deming, A Dwyer, M Diehn… - Nature reviews Clinical …, 2020 - nature.com
An increasing number of studies are describing potential uses of circulating tumour DNA (ctDNA)
in the care of patients with colorectal cancer. Owing to this rapidly developing area of …
in the care of patients with colorectal cancer. Owing to this rapidly developing area of …
Robust enumeration of cell subsets from tissue expression profiles
We introduce CIBERSORT, a method for characterizing cell composition of complex tissues
from their gene expression profiles. When applied to enumeration of hematopoietic subsets …
from their gene expression profiles. When applied to enumeration of hematopoietic subsets …
Association of reactive oxygen species levels and radioresistance in cancer stem cells
The metabolism of oxygen, although central to life, produces reactive oxygen species (ROS)
that have been implicated in processes as diverse as cancer, cardiovascular disease and …
that have been implicated in processes as diverse as cancer, cardiovascular disease and …
Determining cell type abundance and expression from bulk tissues with digital cytometry
Single-cell RNA-sequencing has emerged as a powerful technique for characterizing cellular
heterogeneity, but it is currently impractical on large sample cohorts and cannot be applied …
heterogeneity, but it is currently impractical on large sample cohorts and cannot be applied …
The prognostic landscape of genes and infiltrating immune cells across human cancers
Molecular profiles of tumors and tumor-associated cells hold great promise as biomarkers of
clinical outcomes. However, existing data sets are fragmented and difficult to analyze …
clinical outcomes. However, existing data sets are fragmented and difficult to analyze …
An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage
Circulating tumor DNA (ctDNA) is a promising biomarker for noninvasive assessment of
cancer burden, but existing ctDNA detection methods have insufficient sensitivity or patient …
cancer burden, but existing ctDNA detection methods have insufficient sensitivity or patient …
[HTML][HTML] Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells
Human breast tumors contain a breast cancer stem cell (BCSC) population with properties
reminiscent of normal stem cells. We found 37 microRNAs that were differentially expressed …
reminiscent of normal stem cells. We found 37 microRNAs that were differentially expressed …
Integrated digital error suppression for improved detection of circulating tumor DNA
High-throughput sequencing of circulating tumor DNA (ctDNA) promises to facilitate
personalized cancer therapy. However, low quantities of cell-free DNA (cfDNA) in the blood and …
personalized cancer therapy. However, low quantities of cell-free DNA (cfDNA) in the blood and …